BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4033771)

  • 1. Platelet secretory products inhibit lipoprotein metabolism in macrophages.
    Phillips DR; Arnold K; Innerarity TL
    Nature; 1985 Aug 22-28; 316(6030):746-8. PubMed ID: 4033771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages.
    Henson DA; St Clair RW; Lewis JC
    Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts.
    Pitas RE; Friera A; McGuire J; Dejager S
    Arterioscler Thromb; 1992 Nov; 12(11):1235-44. PubMed ID: 1420082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a platelet-derived macrophage-binding proteoglycan.
    Mas-Oliva J; Arnold KS; Wagner WD; Phillips DR; Pitas RE; Innerarity TL
    J Biol Chem; 1994 Apr; 269(13):10177-83. PubMed ID: 8144520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein.
    Fuhrman B; Brook GJ; Aviram M
    Atherosclerosis; 1991 Aug; 89(2-3):163-73. PubMed ID: 1793444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet-modified LDL: uptake and metabolism in macrophages].
    Fuhrman B; Brook JG; Aviram M
    Harefuah; 1989 Oct; 117(7-8):177-81. PubMed ID: 2583601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages.
    Aviram M
    Metabolism; 1989 May; 38(5):425-30. PubMed ID: 2725280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
    Geng YJ; Hansson GK
    J Clin Invest; 1992 Apr; 89(4):1322-30. PubMed ID: 1556191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet secretory products in modified lipoprotein metabolism in macrophages.
    Hayashi T; Naito M; Kuzuya M; Funaki C; Tateishi T; Asai K; Kuzuya F
    Artery; 1989; 16(5):248-62. PubMed ID: 2764730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation.
    Maor I; Brook GJ; Aviram M
    Atherosclerosis; 1991 Jun; 88(2-3):163-74. PubMed ID: 1892483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.
    Holvoet P; Perez G; Bernar H; Brouwers E; Vanloo B; Rosseneu M; Collen D
    J Clin Invest; 1994 Jan; 93(1):89-98. PubMed ID: 8282826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages.
    Brown MS; Basu SK; Falck JR; Ho YK; Goldstein JL
    J Supramol Struct; 1980; 13(1):67-81. PubMed ID: 6255257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor.
    Jinnouchi Y; Sano H; Nagai R; Hakamata H; Kodama T; Suzuki H; Yoshida M; Ueda S; Horiuchi S
    J Biochem; 1998 Jun; 123(6):1208-17. PubMed ID: 9604012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of LDL by platelet secretory products induces enhanced uptake and cholesterol accumulation in macrophages.
    Fuhrman B; Maor I; Rosenblat M; Dankner G; Aviram M; Brook JG
    Biochem Med Metab Biol; 1989 Aug; 42(1):9-20. PubMed ID: 2775565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets.
    Banka CL; Black AS; Dyer CA; Curtiss LK
    J Lipid Res; 1991 Jan; 32(1):35-43. PubMed ID: 2010692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma.
    Fong LG; Fong TA; Cooper AD
    J Biol Chem; 1990 Jul; 265(20):11751-60. PubMed ID: 2114402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of normal and abnormal plasma lipoproteins by cultured macrophages.
    Knight BL; Soutar AK
    Agents Actions Suppl; 1984; 16():129-43. PubMed ID: 6592953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
    Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
    Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein.
    Hussein O; Brook GJ; Aviram M
    Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.
    Fogelman AM; Shechter I; Seager J; Hokom M; Child JS; Edwards PA
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2214-8. PubMed ID: 6769124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.